Diadon, So we are doing the final data analysis ourselves in house and will release news giving the market our opinion on the results  good or bad, meeting the endpoint/target whatever you want to call it and then I pressume we also say we intend to take our findings to the FDA for approval to go to market , is that right ?

Certainly allows for a very violent ride over the next few months, what happens if we come out with data that looks great to us and the FDA then comes back and says "  yeah but ".................

Fiat500 .............Bently............Fiat500..........I don't know if can handle that kind of ride !!!! 

I'm surprised we don't submit our data to the FDA with a plan following the procedure in the" breakthrough " piece you posted and get some form of approval before releasing anything to the public.